Association between total oxytocin dose and maternal and neonatal morbidity during labour induction: a retrospective study. [PDF]
Payrastre C +5 more
europepmc +1 more source
Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines: the Sexual and Reproductive Health Context [PDF]
Hunt, PH, Khosla, R
core
Timing of Prostin E2 Administration After Poor Response to Propess: Impact on Induction-to-Birth Interval and Maternal/Neonatal Outcomes. [PDF]
Ting NS, Wei YC, Ding DC.
europepmc +1 more source
Carbetocin for Postpartum Haemorrhage Prophylaxis in All Births: A Retrospective Cohort Study Following Policy Change in Routine Uterotonic Use. [PDF]
McKimmie-Doherty M +6 more
europepmc +1 more source
Risk Factors and Postpartum Hemorrhage among Women with Vaginal Delivery. [PDF]
Dube R +5 more
europepmc +1 more source
Puerperal uterine inversion- mismanaged third stage of labour: A diagnostic challenge. [PDF]
Anne S, Singh N, Garg A, Sibi E.
europepmc +1 more source
Balloon plus oxytocin or oral misoprostol for labour induction in prelabour rupture of membranes (PROM): protocol for a randomised controlled trial (RUBAPRO2). [PDF]
Rouzaire M +10 more
europepmc +1 more source
Access to oxytocin, misoprostol, heat-stable carbetocin and tranexamic acid for management of postpartum haemorrhage in the Democratic Republic of the Congo, India and Kenya: a cross-sectional survey of drug availability and pricing. [PDF]
Metzler M +5 more
europepmc +1 more source
Comparison of the effectiveness and safety of vaginal and sublingual low-dose misoprostol versus vaginal dinoprostone for labor ınduction: A retrospective cohort study. [PDF]
Eminov E, Eminov A.
europepmc +1 more source

